Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ANABANAB
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ANAPTYSBIO INC

GOLDMAN SACHS GROUP INC holds 584,070 shares of ANAB (ANAPTYSBIO INC), worth $39.4M as of 2026-Q2. The position was increased (+75.5% shares). ANAB represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$39.4M

Current Shares

584,070

Total Value Change

+$27.7M

Total Shares Change

+233,706

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
584,070
+75.5%
$39.4M0.0%$67.50
44
2026-Q1
Decreased
332,743
-16.6%
$18.5M0.0%$36.97
0
2025-Q4
Increased
398,914
+20.9%
$19.3M0.0%$32.32
34
2025-Q3
Increased
329,820
+17.9%
$10.1M0.0%$20.41
32
2025-Q2
Decreased
279,835
-0.3%
$6.2M0.0%$14.80
0
2025-Q1
Decreased
280,577
-33.0%
$5.2M0.0%$12.39
0
2024-Q4
Increased
419,106
+19.6%
$5.5M0.0%$8.83
32
2024-Q3
Increased
350,364
+80.1%
$11.7M0.0%$22.33
43

Other major holders of ANAB: ADAGE CAPITAL PARTNERS GP, L.L.C., Janus Henderson Group Ltd., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used